Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Malnutrition 1 Hyperphagia 1 Hematopoietic and Lymphatic System Neoplasm 1 Esophageal Neoplasms 1

Interventions

Fluorouracil 10 Oxaliplatin 8 Capecitabine 7 Specimen Handling 6 Nivolumab 6 Leucovorin 6 trastuzumab deruxtecan 5 Magnetic Resonance Spectroscopy 5 pembrolizumab 4 fludarabine 4 Paclitaxel 4 Docetaxel 4 Cyclophosphamide 4 Cisplatin 4 Biopsy 4 aldesleukin 3 Trastuzumab 3 zimberelimab 2 ulixertinib 2 fludarabine phosphate 2 Ramucirumab 2 Irinotecan 2 Folfox protocol 2 zolbetuximab 1 zanidatamab 1 trifluridine tipiracil drug combination 1 trastuzumab biosimilar HLX02 1 trametinib 1 toripalimab 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Parenteral Nutrition × 30 days × Clear all

NCT07604857 2026-05-22

BRIDGE-GC

The Catholic University of Korea

Phase NA Completed

Gastrointestinal

Hyperphagia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡